Pharmacy Chain 36.6 announces preliminary results for 1Q200612.04.2006 APRIL 12, 2006, MOSCOW – OAO Pharmacy Chain 36.6 [RTS: APTK; MICEX: RU14APTK1007] announces its preliminary operational results for the first quarter of 2006 according to management reporting. Consolidated results- Consolidated sales for 1Q2006 amounted to about $92.8 million, which represents a 42.3% increase year on year.
- Pharmacy Chain 36.6’s debt totaled $115.2 million, which represents 5.9% growth from the end of the year.
Retail- Retail sales reached $72.8 million, representing a 59.7% increase over the first quarter of 2005. During 1Q2006 over 12 million purchases (57.3% increase year on year) were made in 36.6 pharmacies. The average ticket totalled $6.30.
- As of 31 March 2006, Pharmacy Chain 36.6 included 512 pharmacies situated in 65 cities in 21 regions throughout Russia. Pharmacies outside Moscow accounted for 42.5% of sales revenues in 1Q2006.
- In 1Q2006 Pharmacy Chain 36.6 organically opened 17 pharmacies, 10 pharmacies were re-branded. Pharmacy Chain 36.6 acquired 2 pharmacy chains: Farmatsiya (Permskie apteki) in the Perm region, which has 37 pharmacies and Farmakom in the city of Omsk with 13 pharmacies. Same store sales in pharmacies, which opened before 2005 totalled 11.9%.
- In 1Q2006, Pharmacy Chain 36.6 together with producers Unipharm (Vitrum vitamines) and Kimberley-Clark (Kotex and Huggies brands) launched a new television advertising campaign. This campaign covers the 10 biggest cities of Russia and promotes special offers to the Company’s customers.
Veropharm- In 1Q2006 Veropharm sales increased by 25.3% year on year and reached $18.8 million.
- In 1Q2006 Veropharm started production of innovative antibiotic drugs under the “Factive” brand. This new medicine is manufactured under the Korean LG LS license, which covers its production and distribution throughout Russia and CIS countries.
Non-audited 1Q2006 in accordance with IFRS reporting is planned for the end of the first half of 2006 and will be released together with audited full year 2005 financial results. | 
